Search

Your search keyword '"Millhauser GL"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Millhauser GL" Remove constraint Author: "Millhauser GL"
133 results on '"Millhauser GL"'

Search Results

2. Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity

3. Exploring the peptide 310-helix ? ?-helix equilibrium with double label electron spin resonance

6. Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity

7. Photocatalytic Generation of Singlet Oxygen by Graphitic Carbon Nitride for Antibacterial Applications.

8. N-glycosylation is a potent regulator of prion protein neurotoxicity.

9. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.

10. EPR of copper centers in the prion protein.

11. Photodynamic Activity of Graphene Oxide/Polyaniline/Manganese Oxide Ternary Composites toward Both Gram-Positive and Gram-Negative Bacteria.

12. Copper(II) Binding to PBT2 Differs from That of Other 8-Hydroxyquinoline Chelators: Implications for the Treatment of Neurodegenerative Protein Misfolding Diseases.

13. Membrane orientation and oligomerization of the melanocortin receptor accessory protein 2.

14. Evidence for aggregation-independent, PrP C -mediated Aβ cellular internalization.

15. Both N-Terminal and C-Terminal Histidine Residues of the Prion Protein Are Essential for Copper Coordination and Neuroprotective Self-Regulation.

16. Intrinsic toxicity of the cellular prion protein is regulated by its conserved central region.

17. Determination of the melanocortin-4 receptor structure identifies Ca 2+ as a cofactor for ligand binding.

18. Production of Artificially Doubly Glycosylated, 15 N Labeled Prion Protein for NMR Studies Using a pH-Scanning Volatile Buffer System.

19. First Synthesis of Mn-Doped Cesium Lead Bromide Perovskite Magic Sized Clusters at Room Temperature.

20. Antimicrobial activity of graphene oxide quantum dots: impacts of chemical reduction.

21. Charge Characteristics of Agouti-Related Protein Implicate Potent Involvement of Heparan Sulfate Proteoglycans in Metabolic Function.

22. Altered Domain Structure of the Prion Protein Caused by Cu 2+ Binding and Functionally Relevant Mutations: Analysis by Cross-Linking, MS/MS, and NMR.

23. X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.

24. Molecular Features of the Zn 2+ Binding Site in the Prion Protein Probed by 113 Cd NMR.

25. Late onset obesity in mice with targeted deletion of potassium inward rectifier Kir7.1 from cells expressing the melanocortin-4 receptor.

26. Photo-enhanced antibacterial activity of ZnO/graphene quantum dot nanocomposites.

27. Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity.

28. The N-terminus of the prion protein is a toxic effector regulated by the C-terminus.

29. The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects.

30. Copper- and Zinc-Promoted Interdomain Structure in the Prion Protein: A Mechanism for Autoinhibition of the Neurotoxic N-Terminus.

31. Interaction between Prion Protein's Copper-Bound Octarepeat Domain and a Charged C-Terminal Pocket Suggests a Mechanism for N-Terminal Regulation.

33. Human β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid.

34. Electrostatic Similarity Analysis of Human β-Defensin Binding in the Melanocortin System.

35. n-Dopants Based on Dimers of Benzimidazoline Radicals: Structures and Mechanism of Redox Reactions.

36. G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.

37. Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation.

38. Genetic Incorporation of the Unnatural Amino Acid p-Acetyl Phenylalanine into Proteins for Site-Directed Spin Labeling.

39. Copper-zinc cross-modulation in prion protein binding.

40. Tyrosine nitration in peptides by peroxynitrite generated in situ in a light-controlled platform: effects of pH and thiols.

41. Combined EXAFS and DFT structure calculations provide structural insights into the 1:1 multi-histidine complexes of Cu(II) , Cu(I) , and Zn(II) with the tandem octarepeats of the mammalian prion protein.

42. Adapter reagents for protein site specific dye labeling.

43. PrP overdrive: does inhibition of α-cleavage contribute to PrP(C) toxicity and prion disease?

44. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.

45. New insights into metal interactions with the prion protein: EXAFS analysis and structure calculations of copper binding to a single octarepeat from the prion protein.

46. Mechanistic study on the solution-phase n-doping of 1,3-dimethyl-2-aryl-2,3-dihydro-1H-benzoimidazole derivatives.

47. Molecular and functional analysis of human β-defensin 3 action at melanocortin receptors.

48. A novel α-synuclein missense mutation in Parkinson disease.

49. Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface.

50. The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaques.

Catalog

Books, media, physical & digital resources